Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.42.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.106NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.3.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.45.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.102NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.105NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used